Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).
Pinto C, Di Fabio F, Siena S, Cascinu S, Rojas Llimpe FL, Ceccarelli C, Mutri V, Giannetta L, Giaquinta S, Funaioli C, Berardi R, Longobardi C, Piana E, Martoni AA. Pinto C, et al. Among authors: berardi r. Ann Oncol. 2007 Mar;18(3):510-7. doi: 10.1093/annonc/mdl459. Epub 2006 Dec 12. Ann Oncol. 2007. PMID: 17164226 Free article. Clinical Trial.
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V; Italian Group for the Study of Digestive Tract Cancer (GISCAD). Cascinu S, et al. Among authors: berardi r. Br J Cancer. 2004 Apr 19;90(8):1521-5. doi: 10.1038/sj.bjc.6601752. Br J Cancer. 2004. PMID: 15083179 Free PMC article. Clinical Trial.
Pre-operative treatment modalities in gastric cancer patients.
Scartozzi M, Berardi R, Pierantoni C, Cascinu S. Scartozzi M, et al. Among authors: berardi r. Ann Oncol. 2005 May;16 Suppl 4:iv106-109. doi: 10.1093/annonc/mdi918. Ann Oncol. 2005. PMID: 15923409 Free article. Review. No abstract available.
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.
Scartozzi M, Sobrero A, Gasparini G, Berardi R, Catalano V, Graziano F, Barni S, Zaniboni A, Beretta GD, Labianca R, Cascinu S; Italian Group for the Study of Digestive Tract Cancer. Scartozzi M, et al. Among authors: berardi r. Oncology. 2005;68(2-3):212-6. doi: 10.1159/000086776. Epub 2005 Jul 7. Oncology. 2005. PMID: 16015036
New target therapies in advanced pancreatic cancer.
Cascinu S, Verdecchia L, Valeri N, Berardi R, Scartozzi M. Cascinu S, et al. Among authors: berardi r. Ann Oncol. 2006 May;17 Suppl 5:v148-52. doi: 10.1093/annonc/mdj971. Ann Oncol. 2006. PMID: 16807445 Free article. Review.
634 results